Results 191 to 200 of about 118,373 (346)
Upgrading upflow anaerobic sludge blanket (UASB) reactors with rice straw biochar: a smart pathway for rural sanitation, bioenergy recovery& agricultural reuse. [PDF]
Nessem N +6 more
europepmc +1 more source
Bioremediation of diesel fuel-contaminated soils in the Atacama Desert, Chile [PDF]
Antizar Ladislao, Blanca +4 more
core
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff +11 more
wiley +1 more source
Exploring specific biomarkers in blood for <i>in vitro</i> diagnosis of caprine tuberculosis. [PDF]
Velasco C +10 more
europepmc +1 more source
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Scalable Miniemulsion Polymerization of Methyl Methacrylate (MMA) in Continuous Flow. [PDF]
Dev Ammini G +3 more
europepmc +1 more source
Validation of RELAP5 model of experimental test rig simulating the natural convection in MTR research reactors [PDF]
Alaa Khedr +3 more
openalex
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
Full-Scale UV-LED Validation with Organism-Specific Dose Determination. [PDF]
Ray H, Atkinson AJ.
europepmc +1 more source

